Search

Author/Creator Khanna, Rashna

1. [P1–044]: SAFETY OF SOLANEZUMAB IN PHASE 3 STUDIES IN INDIVIDUALS WITH MILD ALZHEIMER's DISEASE DEMENTIA. (1st July 2017)

Authors:
Carlson, Christopher D.; Anglin, Greg; Case, Michael G.; Crowe, Brenda; Hake, Ann Marie; Khanna, Rashna; Kryzhanovskaya, Ludmila; Perahia, David; Sethuraman, Gopalan; Yaari, Roy; Dowsett, Sherie A.; Siemers, Eric R.
Journal:
Alzheimer's & dementia
Issue:
Volume 13:Supplement 7S(2017)Part 5
Page Start:
P251
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Interim results of a prospective, randomized, open-label, Phase 3 study of the long-term safety and efficacy of lasmiditan for acute treatment of migraine (the GLADIATOR study). (October 2019)

Authors:
Brandes, Jan Lewis; Klise, Suzanne; Krege, John H; Case, Michael; Khanna, Rashna; Vasudeva, Raghavendra; Raskin, Joel; Pearlman, Eric M; Kudrow, David
Journal:
Cephalalgia
Issue:
Volume 39:Number 11(2019)
Page Start:
1343
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. P2‐007: Exposure‐Adjusted Analysis of Treatment‐Emergent Adverse Events from Expedition and Expedition2 Trials of Solanezumab for The Treatment of Alzheimer's Disease. (1st July 2016)

Authors:
Carlson, Christopher D.; Hake, Ann Marie; Sethuraman, Gopalan; Khanna, Rashna; Salinas, Claudia A.; Siemers, Eric R.
Journal:
Alzheimer's & dementia
Issue:
Volume 12:Supplement 7S(2016)Part 12
Page Start:
P610
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗